... The mainstay treatments for spondyloarthritis are disease-modifying antirheumatic drugs (DMARDs), such as methotrexate and biologic tumor necrosis factor (TNF) inhibitors adalimumab (Humira), infliximab-dyyb (Inflectra), and golimumab (Simponi).Starting treatment early can delay or even prevent irreversible spine curvature, limited mobility, and disability ...
Is Axial Spondyloarthritis Underdiagnosed in Women?
... The mainstay treatments for spondyloarthritis are disease-modifying antirheumatic drugs (DMARDs), such as methotrexate and biologic tumor necrosis factor (TNF) inhibitors adalimumab (Humira), infliximab-dyyb (Inflectra), and golimumab (Simponi).Starting treatment early can delay or even prevent irreversible spine curvature, limited mobility, and disability ...